* JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | 13/11 | 14,28% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | 13/11 | 14,22% |
| * JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | 13/11 | 5,33% |
| ** JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | 13/11 | 14,52% |
| * JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | 13/11 | 5,63% |
| * JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | 13/11 | 5,14% |
| * JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | 13/11 | 13,09% |
| * JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | 13/11 | 4,30% |
| ** JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | 13/11 | 14,66% |
| * JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | 13/11 | 5,78% |
| * JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | 13/11 | 5,46% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | 13/11 | 14,57% |
| *** JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | 13/11 | 8,25% |
| *** JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | 13/11 | 8,46% |
| ** JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | 13/11 | 5,40% |
| * JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | 13/11 | 2,18% |
| **** JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | 13/11 | 8,96% |
| *** JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | 13/11 | 7,65% |
| *** JPM TOTAL EMERGING MARKETS INCOME D (ACC) USD | 13/11 | 7,85% |
| * JPM TOTAL EMERGING MARKETS INCOME D (DIV) EUR | 13/11 | 1,60% |
